Annexon ANNX
NASDAQ ANNX
$4.83 -0.01 (-0.21%)
As of: Sep 4, 2026 · 12:50 PM EDT

Annexon (ANNX) Consolidated Net Income (2019 - 2026)

Annexon (ANNX) posted quarterly Consolidated Net Income of -$78.1 million for Q1 2026, down 9.25% year-over-year from -$86.0 million in Q1 2025, and down 15.75% quarter-over-quarter from -$67.4 million in Q4 2025.

Analysis

Annexon (ANNX) Consolidated Net Income (2019 - 2026) Analysis & Trends

Annexon's Consolidated Net Income history runs 8 years deep, the most recent figure standing at -$78.1 million for Q1 2026.

  • In Q1 2026, Consolidated Net Income fell 9.25% year-over-year to -$78.1 million; the TTM figure through Mar 2026 stood at -$268.0 million (up 4.7% YoY), while the FY2025 annual figure was -$441.3 million, down 31.76% from the prior year.
  • Consolidated Net Income for Q1 2026 stood at -$78.1 million, down from -$67.4 million in the prior quarter.
  • The five-year high for Consolidated Net Income was -$40.0 million in Q4 2022, with the low at -$160.9 million in Q4 2023.
  • The 5-year median for Consolidated Net Income is -$71.5 million (2025), against an average of -$74.2 million.
  • The sharpest annual moves came in 2023 and 2024: Consolidated Net Income sank 302.25% in 2023, then jumped 64.82% in 2024.
  • Annexon's Consolidated Net Income stood at -$40.0 million in 2022, then tumbled by 302.25% to -$160.9 million in 2023, then surged by 64.82% to -$56.6 million in 2024, then fell by 19.16% to -$67.4 million in 2025, then retreated by 15.75% to -$78.1 million in 2026.
  • Business Quant data shows ANNX's Consolidated Net Income at -$78.1 million in Q1 2026, -$67.4 million in Q4 2025, and -$62.6 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Vertex Pharmaceuticals 139.62 Bn 131.77 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.73 Bn 77.73 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 63.53 Bn 58.35 Bn 1.37 Bn 601.00 Mn
4 Moderna 58.23 Bn 53.09 Bn 52.00 Mn -782.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn - -644.37 Mn
6 BeOne Medicines 40.03 Bn 34.93 Bn 1.53 Bn 237.01 Mn
7 Alnylam Pharmaceuticals 35.50 Bn 32.19 Bn 992.69 Mn 164.49 Mn
8 Royalty Pharma 28.52 Bn 27.68 Bn - 81.49 Mn
9 Insmed 27.46 Bn 26.30 Bn 358.27 Mn -13.27 Mn
10 Annexon 972.86 Mn 972.86 Mn - -57.23 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -57.23 Mn
Mar 31, 2026 -46.11 Mn
Dec 31, 2025 -50.21 Mn
Sep 30, 2025 -57.00 Mn
Jun 30, 2025 -51.73 Mn
Mar 31, 2025 -57.51 Mn
Dec 31, 2024 -52.54 Mn
Sep 30, 2024 -39.28 Mn
Jun 30, 2024 -33.57 Mn
Mar 31, 2024 -28.61 Mn
Dec 31, 2023 -29.95 Mn
Sep 30, 2023 -34.73 Mn
Jun 30, 2023 -37.64 Mn
Mar 31, 2023 -41.08 Mn
Dec 31, 2022 -36.67 Mn
Sep 30, 2022 -36.03 Mn
Jun 30, 2022 -37.47 Mn
Mar 31, 2022 -35.62 Mn
Dec 31, 2021 -37.56 Mn
Sep 30, 2021 -35.60 Mn